Vertex Pharmaceuticals, Inc [VRTX] stock prices are up 0.93% to $412.11 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The VRTX shares have gain 2.34% over the last week, with a monthly amount drifted -10.82%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vertex Pharmaceuticals, Inc [NASDAQ: VRTX] stock has seen the most recent analyst activity on December 20, 2024, when H.C. Wainwright reiterated its Buy rating and also revised its price target to $535 from $600. Previously, Oppenheimer downgraded its rating to Perform on December 19, 2024. On December 09, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $550 on the stock. Citigroup started tracking the stock assigning a Buy rating and suggested a price target of $575 on November 14, 2024. Scotiabank initiated its recommendation with a Sector Perform. In a note dated August 05, 2024, Barclays downgraded an Equal Weight rating on this stock and boosted its target price from $472 to $509.
The stock price of Vertex Pharmaceuticals, Inc [VRTX] has been fluctuating between $377.85 and $519.88 over the past year. Currently, Wall Street analysts expect the stock to reach $528.2 within the next 12 months. Vertex Pharmaceuticals, Inc [NASDAQ: VRTX] shares were valued at $412.11 at the most recent close of the market. An investor can expect a potential return of 28.17% based on the average VRTX price forecast.
Analyzing the VRTX fundamentals
The Vertex Pharmaceuticals, Inc [NASDAQ:VRTX] reported sales of 10.62B for trailing twelve months, representing a surge of 11.86%. Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.02, Equity is -0.03 and Total Capital is -0.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 408.78 points at the first support level, and at 405.45 for the second support level. However, for the 1st resistance point, the stock is sitting at 413.90, and for the 2nd resistance point, it is at 415.69.
Ratios To Look Out For
It’s worth pointing out that Vertex Pharmaceuticals, Inc [NASDAQ:VRTX]’s Current Ratio is 2.47. Further, the Quick Ratio stands at 2.20, while the Cash Ratio is 1.32. Considering the valuation of this stock, the price to sales ratio is 10.00, the price to book ratio is 6.80.
Transactions by insiders
Recent insider trading involved ALTSHULER DAVID, EVP, Chief Scientific Officer, that happened on Nov 15 ’24 when 15.0 shares were sold. Officer, ALTSHULER DAVID completed a deal on Nov 15 ’24 to buy 15.0 shares. Meanwhile, EVP & Chief Financial Officer WAGNER CHARLES F JR sold 3000.0 shares on Nov 11 ’24.
